New Genetic Strategy Fights Drug-Resistant Prostate Cancer

An international team has developed a new genetic strategy to combat drug-resistant prostate cancer. This innovative approach leverages genetic mutations in tumors to train the immune system to identify and attack cancer cells, offering hope for broader patient groups. The findings were published in the journal Cancer Discovery.

Read the full story on Quick Digest